Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - October 2013

To SEC-MALS & Beyond - The Road to Biotherapeutic Development Illuminated by Light Scattering

01 Oct 2013 - 01 Oct 2013 - Online Webinar

Bookmark and Share

We present HPLC/SEC-MALS, the technique for quantifying absolute molecular weight, size, polydispersity, aggregation and degree of conjugation. Developers of biopharmaceuticals rely on Wyatt Technology's SEC-MALS products to navigate the path to drug product with confidence.  We review how the Wyatt light scattering instruments constitute a unique set of orthogonal and complementary methods alongside SEC-MALS: SEC-DLS for size & conformation; FFF-MALS for separation & characterization; CG-MALS for intermolecular interactions, and microwell plate-based DLS for high-throughput screening.

Who should attend:
• Researchers assessing biomolecular quality, including size and concentration of aggregates, degree of polymer conjugation, and column interactions
• Protein chemists optimizing production, modification, and formulation of biotherapeutic lead molecules
• Laboratory Managers/Directors/Supervisors performing biophysical characterization

Questions to be answered:
• How do MALS and DLS increase the chromatography data value for advanced analysis of IgG, ADCs, PEGylated proteins, and new format biotherapeutics?
• How can batch light scattering contribute to assessing stability and developing robust formulations?

Further information
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Less Frequent Cervical Cancer Screening
HPV-vaccinated women may only need one screening every 5 to 10 years with screening starting later in life.
The Power Of Orthogonality In Assessing The Stability Of Biopharmaceuticals
By utilizing orthogonal techniques, researchers can maximize the secure application of all analytical results generated.
Dysfunction in Neuronal Transport Mechanism Linked to Alzheimer’s
Findings confirm mutation-caused problem but also reveal a new therapeutic target.
New Antibody Therapy Permanently Blocks SIV Infection
An international research team has developed an effective treatment strategy against the HIV-like Simian Immunodeficiency Virus (SIV) in rhesus macaques.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Zika Vaccines Prevent Disorders in Newborn Mice
Disorder immunity transmitted from female mice to pups following vaccination with two Zika vaccines.
Antibody Drug Conjugates May Help Personalize Radiotherapy
Biomarker-driven study shows promise in sensitizing HER2 positive tumors to radiation and chemotherapy.
DNA Vaccines Protect Monkeys Against Zika Virus
Two experimental Zika virus DNA vaccines developed by NIH scientists protected monkeys against Zika infection.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos